Nutex Health Inc. (NUTX) stock
NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3067% below fair value
$171.41−17.78 (-9.40%)
Close on Nov 12, 2026Market cap $1.17BP/E 7.3Yield –
Nutex Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nutex Health's ebitda for the twelve months ending Sep 30, 2026 was $332.62M, down 12.4% year over year. For fiscal 2025 it was $296.16M, up 97.9% from the year before. The highest annual figure on record is $296.16M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $296.16M | +97.9% |
| FY2024 | Dec 31, 2024 | $149.67M | – |
| FY2023 | Dec 31, 2023 | -$14.18M | – |
| FY2022 | Dec 31, 2022 | -$393.47M | -321.1% |
| FY2021 | Dec 31, 2021 | $177.93M | +11.9% |
| FY2020 | Dec 31, 2020 | $159.07M | – |
| FY2019 | Dec 31, 2019 | -$6.74M | – |
| FY2018 | Dec 31, 2018 | -$837.71K | – |
| FY2014 | Dec 31, 2014 | -$660.18K | – |
| FY2013 | Dec 31, 2013 | -$687.13K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $82.72M | -38.9% |
| Q2 FY2026 | Jun 30, 2026 | $127.04M | +226.3% |
| Q1 FY2026 | Mar 31, 2026 | $86.76M | +1.2% |
| Q4 FY2025 | Dec 31, 2025 | $36.11M | -69.8% |
| Q3 FY2025 | Sep 30, 2025 | $135.37M | +825.0% |
| Q2 FY2025 | Jun 30, 2025 | $38.93M | +295.9% |
| Q1 FY2025 | Mar 31, 2025 | $85.75M | +1421.5% |
| Q4 FY2024 | Dec 31, 2024 | $119.49M | – |
| Q3 FY2024 | Sep 30, 2024 | $14.64M | +272.9% |
| Q2 FY2024 | Jun 30, 2024 | $9.83M | +158.3% |
| Q1 FY2024 | Mar 31, 2024 | $5.64M | – |
| Q4 FY2023 | Dec 31, 2023 | -$21.46M | – |
| Q3 FY2023 | Sep 30, 2023 | $3.92M | – |
| Q2 FY2023 | Jun 30, 2023 | $3.81M | +117.0% |
| Q1 FY2023 | Mar 31, 2023 | -$451.34K | -101.4% |
| Q4 FY2022 | Dec 31, 2022 | -$2.51M | -114.5% |
| Q3 FY2022 | Sep 30, 2022 | -$424.35M | -655.9% |
| Q2 FY2022 | Jun 30, 2022 | $1.75M | -94.1% |
| Q1 FY2022 | Mar 31, 2022 | $31.64M | – |
| Q4 FY2021 | Dec 31, 2021 | $17.33M | -89.0% |
| Q3 FY2021 | Sep 30, 2021 | $76.33M | +4372.5% |
| Q2 FY2021 | Jun 30, 2021 | $29.83M | +4279.5% |
| Q1 FY2021 | Mar 31, 2021 | -$4.15M | – |
| Q4 FY2020 | Dec 31, 2020 | $157.58M | – |
| Q3 FY2020 | Sep 30, 2020 | $1.71M | – |
| Q2 FY2020 | Jun 30, 2020 | $681.08K | – |
| Q1 FY2020 | Mar 31, 2020 | -$892.80K | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.50M | – |
| Q3 FY2019 | Sep 30, 2019 | -$890.67K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$914.81K | – |
| Q1 FY2017 | Mar 31, 2017 | -$150.47K | – |
See a number that looks wrong?